International Forum on Quality & Safety in Healthcare Paris 2014

 

Improve Quality. Reduce Costs. Save Lives.

Now in its 19th year, the International Forum is an annual gathering of healthcare professionals in quality improvement and patient safety. The International Forum supports and energises the movement for healthcare improvement. This four day event connects healthcare leaders and practitioners worldwide to improve outcomes for patients and communities.

The International Forum, a completely sold out event in 2013, attended by over 3,300 people from over 80 countries, continues to deliver inspiring content and opportunities to expand your network, learn from experiences and gather new practical ideas for your quality improvement and patient safety initiatives.

Submit an abstract on your quality improvement or patient safety initiatives by 4 November 2013 and get your poster displayed at the International Forum in Paris. A number of the best abstracts will also be published in BMJ Quality & Safety and the European Journal of Hospital Pharmacy (EJHP).

For more information and Forum registrations visit http://internationalforum.bmj.com

 

EFGCP Interactive Investigator Training for Inspections

This one-day course is aimed at clinical trial centre staff  such as investigators, co-investigators, study nurses and coordinators and anyone who is involved in the conduct of clinical trials of any phase and design, sponsored by commercial or academic institutions. Inspections are no longer linked to a submission by a sponsor to Health Authorities to obtain a marketing authorization but in the today’s inspection landscape inspections can occur at any time with and without a particular event triggering these. Especially in Europe, Health Authorities conduct inspections as part of their routine oversight activity. For clinical trial centre staff it is, therefore, important to understand what is required during an inspection, how to prepare for and follow-up on an inspection. It is also important to understand and apply new trends such as the concept of a risk based approach that is becoming the reference for inspectors.

EFGCP Workshop on ‘A Practical Approach to Risk-Based Monitoring’

The specific role of the Education Working Party at EFGCP is to identify priority needs and primary challenges in the education and training of GCP among the various parties involved in preparing and carrying out clinical trials. As the multi-centre and multi-country clinical trials increase across Europe, there is a need to focus on the co-ordination and harmonisation of educational and training programs in GCP. At the same time, it is becoming more and more evident that different traditions in medical and scientific education across Europe need to be appreciated in developing GCP practices.

Over the last year several key documents have been developed globally by regulatory authorities indicating the universal trend to a risk-based monitoring approach. The regulators recognise there have been considerable advances in technology since the release of ICH GCP back in 1996. Risk management is also an area which is often poorly understood as is the use of risk management tools. Identifying risk and mitigation as well as establishing priorities and quality tolerance limits require a stratified approach. In the UK, during 2011 the MHRA have also started to look at risk-adaptive approaches in the management of clinical trials. More recently, the Commission has adopted a “Proposal for a Regulation of the European Parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC" ("Clinical Trials Regulation") which also needs to be considered.

The Education Working party is currently developing materials on risk-based monitoring. This potentially flexible approach to monitoring is possible especially with the use of current technologies but many have been reluctant to follow this route. It was recognised early in EFGCP’s process of developing risk-based training that despite all the discussions about adaptive monitoring, how clinical researchers should develop this approach at a practical level is less easy to understand. This new approach needs to ensure that subjects are protected on clinical trials and that data quality is not compromised. The aim of the Workshop is to interact directly with the regulators and other interested groups in order to discuss what can realistically be achieved and to define when researchers still need to follow more traditional approaches.

WIN 2013 Symposium “Personalized Cancer Therapy: From Innovation to Implementation”

The WIN 2013 Symposium is the fifth in an annual series of multi-sector, worldwide Symposia dedicated to the advancement of personalized cancer medicine. The theme of WIN2013, taking place July 10-12, 2013, in Paris, France, is:

Personalized Cancer Therapy: From Innovation to Implementation

Join leaders from around the world in a collaborative, global forum to learn about and share innovations that represent the most promising advances in personalized cancer care. Globally-recognized experts from academia, pharma, life-sciences, healthcare IT, regulatory, and patient advocacy will present in plenary sessions on:

  • OMICS assays that support personalized clinical care today
    Moderator: Alexander Eggermont, Institut Gustave Roussy (France)
  • Analysis and clinical application of genomics
    Moderator: Levi Garraway, Dana-Farber Cancer Institute (USA)
  • Clinical progress in personalized cancer therapy
    Moderator: Richard L. Schilsky, ASCO (USA)
  • New approaches that impact personalized cancer care
    Moderator: John Mendelsohn, MD Anderson Cancer Center (USA)

WIN2013 is a unique opportunity for all stakeholders in personalized cancer medicine. With extended time for discussion and interaction, the Symposium offers you opportunities to learn from, and network with, leaders from around the globe regarding the most transformational developments in cancer care.

A Practical Guide to Effective Non-Medical Prescribing

http://www.healthcareconferencesuk.co.uk/non-medical-prescribing-training

 
This national conference provides an essential update for current and aspiring nurse and pharmacist prescribers, and will be chaired by Barbara Stuttle CBE Chair of the Association for Nurse Prescribing who led the campaign for nurse prescribing and continues to support non-medical prescribers in their role. 
 
Delegates will hear a national update from the newly formed NICE Medicines and Prescribing Centre on how to deliver the QIPP challenge for medicines use and procurement, plus an overview of the findings from both a review and an audit of non-medical prescribing and what can be learnt to develop non-medical prescribing practice and ensure nurses and pharmacists are able to prescribe safely and effectively to deliver high quality patient care.
 
Personal case study presentations from experienced non-medical prescribers, an extended legal session, and a tips and advice session will provide valuable shared learning and practical guidance for applying in practice.

Professions working together – a collaborative approach to the management of diabetes

We are delighted to bring together this collaborative event between the Royal College of General Practitioners and the Royal Pharmaceutical Society.

This event will explore how we can enable more healthcare to be provided in the community, coordinated around the needs of patients by harnessing better joined up working across professional boundaries. It will look at what potential future models of integrated care will look like and the implications for patients, professionals and commissioners. Closer collaboration and more integration with pharmacy services would free up time for longer consultations in GP surgeries allowing GPs to focus on the more complicated cases, or those of a more serious nature.

EFGCP Annual Conference 2013 & 20th Anniversary: Virtual Future: the ethical dimensions of emerging technologies in clinical trials and research

For twenty years the European Forum of Good Clinical Practice has acted as a forum to bring all parties with an interest in health care research together and debate current topics. The focus of the 2013 Annual Conference will be the ethics of emerging technologies in clinical care, trials and research.

 

The new digital technologies are now part of our lives, shaping and changing our health care and research.   We recognise there is already a large literature on this subject but it’s clear that they raise important ethical questions that we must address. For health care professionals their use must be evidence based; for researchers they must use new methods fairly; for Ethics Committees the fear of the new must not be grounds for unwarranted hostility or even unfavourable review.

 

Our conference will focus on

  1. the importance of researching these interventions before implementation,  and
  2. the ethical use of these technologies in research. 

 

It will particularly address  

  • What can these modern technologies offer health care?
  • How do patients see care using these technologies?
  • How should we research this new care?
  • What are the ethical issues around research using these new technologies and are they any different from those arising from “traditional” research?
  • How do we ensure quality in research using modern technologies?
  • How should we regulate such research when it crosses all regulatory boundaries?
  • Is care and research using modern technologies inclusive or exclusive?

    • What is the effect for vulnerable populations
    • What is the effect for resource poor countries?